Germany
Japan
United Kingdom
China
IL20 goat polyclonal antibody, Biotin
| Applications | ELISA, WB |
| Reactivities | Human |
| Conjugation | Biotin |
| Immunogen | Highly pure (>98%) E.coli derived, 35.2 kDa recombinant Human IL-20. |
Primary Antibodies
Cytokeratin 8 (KRT8) (+ KRT18) guinea pig polyclonal antibody, Serum
| Applications | ELISA, IHC, WB |
| Reactivities | Bovine, Chicken, Hamster, Human, Mouse, Rat, Xenopus |
| Immunogen | Keratin K8/K18 filaments, reconstituted from purified Bovine keratins K8 and K18 |
VIII mouse monoclonal antibody, clone B62-FE2, FITC
| Applications | ELISA |
| Conjugation | FITC |
USD 260.00
2 Weeks
Parathyroid Hormone (PTH) (53-84) mouse monoclonal antibody, clone D1.5, Purified
| Applications | ELISA, IHC |
| Reactivities | Human |
GFP (Ads. to Hu, Ms, Rt Serum Proteins) goat polyclonal antibody, Aff - Purified
| Applications | ELISA, IF, IHC, WB |
| Immunogen | Green Fluorescent Protein (GFP) fusion protein corresponding to the full length amino acid sequence (246 aa) derived from the jellyfish Aequorea victoria |
USD 390.00
In Stock
MHC Class I Heavy Chain (Restricted expression) mouse monoclonal antibody, clone HC10, Purified
| Applications | ELISA, EM, FC, IF, IHC, IP, WB |
| Reactivities | Human |
Biotinylated Anti-Human IL-17E Rabbit Polyclonal Antibody
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | E.coli derived Recombinant Human IL-17E |
MRP8/14 (S100A8/A9) mouse monoclonal antibody, clone 27E10, Purified
| Applications | ELISA, IHC |
| Reactivities | Human |
Vaccinia Virus (Lister Strain) rabbit polyclonal antibody, Purified
| Applications | ELISA, IHC |
| Immunogen | Lister Strain (mixture of virions and infected cell polypeptides) |
CRP mouse monoclonal antibody, clone PC1, Purified
| Applications | ELISA, WB |
| Reactivities | Porcine |
USD 250.00
2 Weeks
ICAM1 mouse monoclonal antibody, clone MEM-111, Purified
| Applications | ELISA, FC, IHC, WB |
| Reactivities | Bovine, Human, Rat |
Canine Parvovirus mouse monoclonal antibody, clone CPV1-2A1, Purified
| Applications | ELISA, IHC |
| Reactivities | Canine, Feline |
USD 260.00
2 Weeks
gamma Tubulin (TUBG1) (434-449) mouse monoclonal antibody, clone TU-32, Aff - Purified
| Applications | ELISA, IF, WB |
| Reactivities | Mammalian, Plant |
Symetric Dimethylarginine (SDMA) rabbit polyclonal antibody, Serum
| Applications | ELISA, IF, IHC, R, WB |
| Immunogen | Symmetric Dimethylarginine (SDMA) KLH-conjugated. |
USD 415.00
2 Weeks
Adeno-Associated Virus 2 / AAV2 (intact particle) mouse monoclonal antibody, clone A20, Purified
| Applications | ELISA, FN, IF, IHC, IP |
| Reactivities | Human, Monkey |
Cystatin C (CST3) rabbit polyclonal antibody, Aff - Purified
| Applications | ELISA, WB |
| Reactivities | Human |
| Immunogen | Cystatin C from Human urine. |
Lipoteichoic Acid (LTA) mouse monoclonal antibody, clone 55, Low Endotoxin
| Applications | ELISA, IF, IHC, WB |
Candida albicans rabbit polyclonal antibody, Purified
| Applications | ELISA, ID, Ie, IF, IHC |
| Reactivities | Candida |
| Immunogen | Candida albicans, type A (ATTCC #32354). |
USD 745.00
5 Days
ACTH (POMC) (1-24) mouse monoclonal antibody, clone 57 (BGN/1388/66), Aff - Purified
| Applications | ELISA, IHC |
| Reactivities | Human, Rat |
beta 2 Microglobulin (B2M) rabbit polyclonal antibody, HRP
| Applications | ELISA, EM, IHC, WB |
| Reactivities | Human |
| Conjugation | HRP |
| Immunogen | Beta-2-Microglobulin [Human Urine]. |
pan Dengue Virus mouse monoclonal antibody, clone Dengue 1-11(3), Purified
| Applications | ELISA, IF, IHC, WB |
Collagen II (COL2A1) rabbit polyclonal antibody, Aff - Purified
| Applications | ELISA, IHC, IP, WB |
| Reactivities | Bovine, Human, Mouse, Rat, Sheep |
| Immunogen | Collagen type II purified from Human knee and Bovine nasal cartilage. |
Testosterone (3-CMO-BSA) mouse monoclonal antibody, clone 7003, Purified
| Applications | ELISA, IF, R |
| Reactivities | Human |
C1QA mouse monoclonal antibody, clone JL-1, Biotin
| Applications | ELISA, FN, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Biotin |
Lyve1 rabbit polyclonal antibody, Purified
| Applications | ELISA, FC, IF, IHC, WB |
| Reactivities | Mouse, Rat |
| Immunogen | Highly pure recombinant Mouse soluble LYVE-1 (Ala24-Gly228) produced in insect cells (Cat.-No DA3524). This recombinant soluble LYVE-1 consists of amino acid 24 (Ala) to 228 (Gly) and is fused to a C-terminal His-tag (6xHis). |
USD 390.00
2 Weeks
MHC Class I Heavy Chain (Restricted expression) mouse monoclonal antibody, clone HCA2, Purified
| Applications | ELISA, FC, IF, IHC, IP, WB |
| Reactivities | Human |
Desmoglein 2 (DSG2) mouse monoclonal antibody, clone 10G11, Purified
| Applications | ELISA, IHC, WB |
| Reactivities | Human |
USD 340.00
2 Weeks
Cytokeratin 19 (KRT19) mouse monoclonal antibody, clone KS19.2(Z105.6), Purified
| Applications | ELISA, IF, IHC, WB |
| Reactivities | Amphibian, Bovine, Chicken, Human, Rat |
Tubulin (TUBA1B) (Tyr-Tubulin) rat monoclonal antibody, clone YL1/2, Purified
| Applications | ELISA, IF, IHC, IP, R, WB |
| Reactivities | Birds, Mammalian, Yeast |
Albumin (ALB) goat polyclonal antibody, FITC
| Applications | ELISA, ID, IF, IHC |
| Reactivities | Human |
| Conjugation | FITC |
| Immunogen | Albumin is isolated from human serum by sequential precipitation and purified by Ion Exchange Chromatography and Affinity Chromatography. Freund’s complete adjuvant is used in the first step of the immunization procedure. |
Collagen I (COL1A1) rabbit polyclonal antibody, Biotin
| Applications | ELISA, FC, IHC, IP, WB |
| Reactivities | Bovine, Human, Mammalian, Mouse, Rat |
| Conjugation | Biotin |
| Immunogen | Collagen Type I from Human and Bovine placenta. |
Active filters
Applications
- ELISA
Filter by
Target Symbol
- H3C1 (37)
- EGFR (32)
- IL6 (29)
- POMC (29)
- ALB (28)
- PDCD1 (28)
- C3 (27)
- TNF (27)
- COL1A1 (26)
- EGF (26)
- S (26)
- CD80 (25)
- MAPT (25)
- S PROTEIN (25)
- GAG (24)
- PTH (24)
- EDN1 (23)
- F13A1 (23)
- FSHB (23)
- NPPA (23)
- IL2 (22)
- PON1 (22)
- SARS-COV-2 SPIKE PROTEIN (22)
- CD274 (21)
- IFNG (20)
- BRAF (19)
- CALCA (19)
- NPPB (19)
- PDYN (19)
- FOLH1 (18)
- IL10 (18)
- LTF (18)
- RBP4 (18)
- B2M (17)
- CSF2 (17)
- IGF1 (17)
- IL17A (17)
- IL7 (17)
- INS (17)
- KITLG (17)
- PENK (17)
- SARS-COV-2 N PROTEIN (17)
- CD44 (16)
- MUC1 (16)
- COL4A1 (15)
- CXCL12 (15)
- FN1 (15)
- GCG (15)
- IL12A (15)
- IL3 (15)
- SAA1 (15)
- AFP (14)
- CCL2 (14)
- CD5 (14)
- IL4 (14)
- IL9 (14)
- MYC (14)
- TP63 (14)
- CD1C (13)
- CRP (13)
- EFNA2 (13)
- EPHX1 (13)
- GFAP (13)
- HA (13)
- KLK3 (13)
- MSMB (13)
- NME1 (13)
- TLE1 (13)
- ADCYAP1 (12)
- CCL3 (12)
- GAL (12)
- GHRL (12)
- HIST1H3A (12)
- IAPP (12)
- MAPK8 (12)
- PRL (12)
- AGT (11)
- CHGA (11)
- DDK (11)
- GAPDH (11)
- IL1B (11)
- KLK8 (11)
- MAP2K1 (11)
- N PROTEIN (11)
- S100A1 (11)
- SERPINB3 (11)
- VCAM1 (11)
- VEGFA (11)
- CCL11 (10)
- CCR5 (10)
- CXCL8 (10)
- ENO2 (10)
- ERG (10)
- FGF2 (10)
- GH1 (10)
- IL16 (10)
- IL5 (10)
- LDHA (10)
- LDLRAP1 (10)
- MDH1 (10)
Reactivities
- Human (4154)
- Mouse (1687)
- Rat (1509)
- Mammalian (126)
- Porcine (98)
- Murine (82)
- Monkey (79)
- SARS-CoV-2 (77)
- Bovine (58)
- Dog (49)
- Rabbit (25)
- Virus (24)
- Canine (19)
- Pig (12)
- Chicken (11)
- Primate (11)
- C-term DDK (10)
- Feline (9)
- Cow (8)
- Goat (8)
- Guinea Pig (8)
- SARS-CoV (8)
- Sheep (8)
- Broad (5)
- Chimpanzee (5)
- Escherichia coli (3)
- Hamster (3)
- Respiratory Syncytial Virus (3)
- Zebrafish (3)
- Avian (2)
- Bacteria (2)
- Cynomolgus (2)
- Dengue virus (2)
- Ferret (2)
- Horse (2)
- Insect (2)
- West Nile Virus (2)
- Yeast (2)
- Yellow Fever Virus (2)
- 5-FAM (1)
- Bacillus Antracis (1)
- Biotin (1)
- Digoxin (1)
- FITC (1)
- Fish (1)
- Fusion proteins containing the Flag Tag (1)
- HIV (1)
- Horseradish Peroxidase (1)
- Staphylococcus aureus (1)
- Xenopus (1)
Antibody Hosts
Isotypes
- IgG (4308)
- IgG1 (3818)
- IgG2a (970)
- IgG2b (683)
- IgG, kappa (160)
- IgG1, kappa (113)
- IgM (92)
- IgG3 (81)
- IgG2a, kappa (30)
- Ig (24)
- IgG2 (24)
- Fab fragment, kappa (17)
- IgG1, lambda (11)
- IgG2b, kappa (11)
- IgY (10)
- IgG1-Fc Fusion (8)
- IgG4 (5)
- IgM, kappa (5)
- IgA-Fc Fusion (4)
- IgG-Fc Fusion (4)
- IgM-Fc Fusion (4)
- IgE (3)
- IgA (2)
- IgG2a, lambda (2)
- IgG3, kappa (1)
- cocktail (1)
Clonalities
Conjugates
Knockout (KO) Validation
Modifications
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (47)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human Fab format, for improved compatibility with existing reagents, assays and techniques. (17)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (13)
- This chimeric human antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. (12)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (12)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (7)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (6)
- This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (6)
- This reformatted human antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (6)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (5)
- This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (5)
- This chimeric mouse antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques. (4)
- This full-length, reformatted human antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (4)
- This full-length, reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (4)
- This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original human scFv format, for improved compatibility with existing reagents, assays and techniques. (3)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (3)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This full-length, chimeric mouse antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (2)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This reformatted human antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- Phospho-specific (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgM format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric murine antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG2 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgM format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric mouse antibody, based on the original rat IgG2b format, created for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original mouse scFv format for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Assay Platforms
Families
- Druggable Genome (3142)
- Secreted Protein (1114)
- Transmembrane (1082)
- Transcription Factors (531)
- ES Cell Differentiation/IPS (451)
- Protein Kinase (310)
- Protease (243)
- Stem cell - Pluripotency (182)
- Adult stem cells (121)
- Embryonic stem cells (95)
- Cancer stem cells (72)
- Induced pluripotent stem cells (67)
- Stem cell relevant signaling - JAK/STAT signaling pathway (62)
- GPCR (54)
- Stem cell relevant signaling - DSL/Notch pathway (37)
- Phosphatase (36)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (32)
- Stem cell relevant signaling - Wnt Signaling pathway (23)
- Ion Channels: Other (19)
- Nuclear Hormone Receptor (19)
- P450 (14)
- Ion Channels: Cys-loop Receptors (6)
- Ion Channels: Glutamate Receptors (4)
- Ion Channels: Potassium (4)
- Ion Channels: Transient receptor potential (4)
- Ion Channels: Cyclic nucleotide gated (1)
- Ion Channels: Sodium (1)
Pathways
- Cytokine-cytokine receptor interaction (511)
- Pathways in cancer (477)
- Metabolic pathways (353)
- MAPK signaling pathway (314)
- Focal adhesion (299)
- Jak-STAT signaling pathway (268)
- Chemokine signaling pathway (231)
- Prostate cancer (219)
- Regulation of actin cytoskeleton (219)
- ErbB signaling pathway (185)
- Hematopoietic cell lineage (180)
- T cell receptor signaling pathway (180)
- Toll-like receptor signaling pathway (178)
- Melanoma (175)
- Systemic lupus erythematosus (165)
- Colorectal cancer (160)
- Pancreatic cancer (159)
- Endometrial cancer (158)
- Glioma (156)
- Bladder cancer (152)
- Neurotrophin signaling pathway (143)
- Complement and coagulation cascades (138)
- Non-small cell lung cancer (138)
- Natural killer cell mediated cytotoxicity (134)
- Chronic myeloid leukemia (133)
- GnRH signaling pathway (130)
- Cell adhesion molecules (CAMs) (128)
- Gap junction (125)
- Insulin signaling pathway (124)
- Acute myeloid leukemia (120)
- Progesterone-mediated oocyte maturation (119)
- Endocytosis (117)
- Fc epsilon RI signaling pathway (117)
- Neuroactive ligand-receptor interaction (117)
- Alzheimer's disease (109)
- NOD-like receptor signaling pathway (109)
- Cell cycle (106)
- Renal cell carcinoma (106)
- ECM-receptor interaction (103)
- Apoptosis (99)
- Wnt signaling pathway (96)
- TGF-beta signaling pathway (92)
- Small cell lung cancer (91)
- Type I diabetes mellitus (89)
- Melanogenesis (87)
- Adipocytokine signaling pathway (86)
- Adherens junction (84)
- Allograft rejection (84)
- B cell receptor signaling pathway (82)
- Epithelial cell signaling in Helicobacter pylori infection (80)
- Graft-versus-host disease (78)
- Fc gamma R-mediated phagocytosis (76)
- RIG-I-like receptor signaling pathway (76)
- Thyroid cancer (76)
- mTOR signaling pathway (74)
- Axon guidance (73)
- Long-term depression (73)
- Vascular smooth muscle contraction (73)
- Prion diseases (71)
- Leukocyte transendothelial migration (70)
- Oocyte meiosis (70)
- Autoimmune thyroid disease (68)
- Hypertrophic cardiomyopathy (HCM) (68)
- Tight junction (66)
- Type II diabetes mellitus (65)
- Calcium signaling pathway (64)
- Long-term potentiation (64)
- p53 signaling pathway (64)
- VEGF signaling pathway (62)
- Glycolysis / Gluconeogenesis (59)
- Amyotrophic lateral sclerosis (ALS) (57)
- Huntington's disease (54)
- PPAR signaling pathway (53)
- Dilated cardiomyopathy (51)
- Dorso-ventral axis formation (51)
- Pathogenic Escherichia coli infection (49)
- Viral myocarditis (49)
- Cytosolic DNA-sensing pathway (47)
- Antigen processing and presentation (45)
- Purine metabolism (45)
- Asthma (42)
- Arginine and proline metabolism (40)
- Cysteine and methionine metabolism (39)
- Notch signaling pathway (39)
- Glutathione metabolism (38)
- Ubiquitin mediated proteolysis (38)
- Metabolism of xenobiotics by cytochrome P450 (37)
- Pyruvate metabolism (37)
- Basal cell carcinoma (29)
- Proteasome (29)
- Regulation of autophagy (29)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (26)
- Pyrimidine metabolism (26)
- Citrate cycle (TCA cycle) (24)
- Maturity onset diabetes of the young (24)
- Parkinson's disease (24)
- Tryptophan metabolism (24)
- Lysosome (23)
- Arachidonic acid metabolism (22)
- Cardiac muscle contraction (21)
- Hedgehog signaling pathway (21)
- Nitrogen metabolism (21)
- Drug metabolism - cytochrome P450 (19)
- Butanoate metabolism (18)
- Glycine (18)
- Propanoate metabolism (18)
- Valine (18)
- leucine and isoleucine degradation (18)
- serine and threonine metabolism (18)
- Base excision repair (17)
- Fatty acid metabolism (17)
- Tyrosine metabolism (17)
- One carbon pool by folate (16)
- RNA degradation (16)
- Fructose and mannose metabolism (15)
- Lysine degradation (15)
- Spliceosome (15)
- Vibrio cholerae infection (15)
- beta-Alanine metabolism (15)
- Alanine (14)
- aspartate and glutamate metabolism (14)
- Histidine metabolism (13)
- Nucleotide excision repair (13)
- Pentose phosphate pathway (13)
- Biosynthesis of unsaturated fatty acids (12)
- Oxidative phosphorylation (12)
- Primary immunodeficiency (12)
- Renin-angiotensin system (12)
- Sphingolipid metabolism (12)
- Nicotinate and nicotinamide metabolism (11)
- Phenylalanine metabolism (11)
- ABC transporters (10)
- Amino sugar and nucleotide sugar metabolism (10)
- Mismatch repair (10)
- Folate biosynthesis (9)
- Homologous recombination (9)
- Non-homologous end-joining (9)
- Olfactory transduction (9)
- Phosphatidylinositol signaling system (9)
- Porphyrin and chlorophyll metabolism (9)
- Riboflavin metabolism (9)
- Starch and sucrose metabolism (9)
- Glycerolipid metabolism (8)
- Glyoxylate and dicarboxylate metabolism (8)
- Methane metabolism (8)
- Retinol metabolism (8)
- Ribosome (8)
- SNARE interactions in vesicular transport (8)
- Selenoamino acid metabolism (8)
- Cyanoamino acid metabolism (7)
- Drug metabolism - other enzymes (7)
- Linoleic acid metabolism (7)
- N-Glycan biosynthesis (7)
- Terpenoid backbone biosynthesis (7)
- Aminoacyl-tRNA biosynthesis (6)
- DNA replication (6)
- Glycerophospholipid metabolism (6)
- Primary bile acid biosynthesis (6)
- Taurine and hypotaurine metabolism (6)
- Ether lipid metabolism (5)
- Galactose metabolism (5)
- Synthesis and degradation of ketone bodies (5)
- Caffeine metabolism (4)
- Inositol phosphate metabolism (4)
- Limonene and pinene degradation (4)
- Androgen and estrogen metabolism (3)
- RNA polymerase (3)
- Taste transduction (3)
- Vitamin B6 metabolism (3)
- Ascorbate and aldarate metabolism (2)
- C21-Steroid hormone metabolism (2)
- Circadian rhythm - mammal (2)
- Fatty acid elongation in mitochondria (2)
- O-Glycan biosynthesis (2)
- Pantothenate and CoA biosynthesis (2)
- Pentose and glucuronate interconversions (2)
- alpha-Linolenic acid metabolism (2)
- leucine and isoleucine biosynthesis (2)
- D-Glutamine and D-glutamate metabolism (1)
- Fatty acid biosynthesis (1)
- Lysine biosynthesis (1)
- Other glycan degradation (1)
- Phenylalanine (1)
- Ubiquinone and other terpenoid-quinone biosynthesis (1)
- tyrosine and tryptophan biosynthesis (1)